- Home
- ACIU vs CURV Comparison
ACIU vs CURV Comparison
Compare ACIU & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | CURV |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 185.4M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACIU | CURV |
|---|---|---|
| Price | $3.68 | $1.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $10.00 | $1.59 |
| AVG Volume (30 Days) | ★ 1.5M | 465.9K |
| Earning Date | 11-04-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,482,957.00 | ★ $1,039,486,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $644.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $0.94 |
| 52 Week High | $4.00 | $7.19 |
Technical Indicators
Market Signals| Indicator | ACIU | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 46.83 |
| Support Level | $3.09 | $1.03 |
| Resistance Level | $3.73 | $1.13 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 91.86 | 49.78 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.